Compare SELLAS Life Sciences Group Inc. Common Stock (SLS) vs State Street Corporation Common Stock (STT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SELLAS Life Sciences Group Inc. Common Stock vs State Street Corporation Common Stock — how do they compare? SELLAS Life Sciences Group Inc. Common Stock trades at $11.33 (market cap $2.27B), while State Street Corporation Common Stock trades at $175.23 (market cap $48.10B). The key difference: State Street Corporation Common Stock is far larger — about 21.2× SELLAS Life Sciences Group Inc. Common Stock's market cap, and State Street Corporation Common Stock pays a 2.1% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| SLS | STT | |
|---|---|---|
Market Cap | $2.27B | $48.10B |
Volume | 4,179,659 | 2,033,865 |
Sector | Health | Financials |
52-Week High | $15.46 | $194.26 |
52-Week Low | $1.39 | $111.00 |
Enterprise Value | $2.14B | $74.64B |
Typical Hold Time | — | 0 Days |
Dividend Yield | — | 2.1% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →About State Street Corporation Common Stock
State Street provides investment servicing, custody, and asset management services to institutional investors. Its asset management business includes the SPDR ETF range.
Read more on STT →
